Prelude Capital Management’s Hims & Hers Health HIMS Stock Holding History

Prelude Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,795	Closed	-$437K	–	1142
2025 Q1	$437K	Sell	14,795 -2,009	-12%	-$74.6K	0.03%	557
2024 Q4	$406K	Buy	16,804 +1,832	+12%	+$45.4K	0.03%	664
2024 Q3	$276K	Buy	14,972 +3,858	+35%	+$69.1K	0.02%	908
2024 Q2	$224K	Sell	11,114 -7,404	-40%	-$123K	0.02%	936
2024 Q1	$286K	Buy	+18,518	New	+$209K	0.02%	919
2021 Q2	–	Sell	-12,542	Closed	-$166K	–	1775
2021 Q1	$166K	Buy	+12,542	New	+$210K	﹤0.01%	1362

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Prelude Capital Management's HIMS Position: Q2 2025 in Review

Prelude Capital Management sold out of Hims & Hers Health (HIMS) in Q2 2025, closing a stake of 14,795 shares — an estimated $437K sold.

Prelude Capital Management first reported a position in HIMS in Q1 2021 and held it in 6 quarters. The position peaked at $437K in Q1 2025. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

Prelude Capital Management reported no remaining Hims & Hers Health position as of Q2 2025 after selling out during the quarter.
Prelude Capital Management sold 14,795 Hims & Hers Health shares in Q2 2025, an estimated $437K.
Prelude Capital Management first reported a position in Hims & Hers Health in Q1 2021 and held it in 6 quarters.
Prelude Capital Management's Hims & Hers Health position peaked at $437K in Q1 2025.
510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.